What Is the Relevance of Antimicrobial Resistance on the Outcome of Community-Acquired Pneumonia Caused by Streptococcus pneumoniae? (Should Macrolide Monotherapy Be Used for Mild Pneumonia?)

被引：14
作者：
Low, Donald E. [1 ,2 ]
机构：
[1] Univ Hlth Network, Dept Microbiol, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[2] Univ Toronto, Toronto, ON M5G 1X5, Canada
来源：
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA | 2013年 / 27卷 / 01期
关键词：
Community-acquired pneumonia; Streptococcus pneumoniae; Antimicrobial resistance; Resistance paradox; Pollyanna phenomenon; Macrolides; beta-lactams; Fluoroquinolones; IN-VITRO RESISTANCE; PNEUMOCOCCAL PNEUMONIA; MYCOPLASMA-PNEUMONIAE; PENICILLIN RESISTANCE; INFECTIOUS-DISEASES; SUSCEPTIBILITY; BACTEREMIA; MORTALITY; SOCIETY; ADULTS;
D O I：
10.1016/j.idc.2012.11.013
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Multidrug-resistant pneumococci continue to increase worldwide. Although there are still questions regarding the relevance of beta-lactam resistance, the recommendation for the use of the macrolides as monotherapy for mild community-acquired pneumonia should be revisited in view of high rates of resistance, the association of clinical failures with low-level and high-level resistance, and the lack of clinical data to support their need for empirical therapy for the atypicals.
引用
收藏
页码：87 / +
页数：12
相关论文
共 36 条
  • [1] Emergence of levofloxacin-resistant pneumococci in immunocompromised adults after therapy for community-acquired pneumonia
    Anderson, KB
    Tan, JS
    File, TM
    DiPersio, JR
    Willey, BM
    Low, DE
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 (03) : 376 - 381
  • [2] PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA
    AUSTRIAN, R
    GOLD, J
    [J]. ANNALS OF INTERNAL MEDICINE, 1964, 60 (05) : 759 - +
  • [3] Bébéar C, 2011, FUTURE MICROBIOL, V6, P423, DOI [10.2217/FMB.11.18, 10.2217/fmb.11.18]
  • [4] Beuhler Michael C., 2012, Morbidity and Mortality Weekly Report, V61, P825
  • [5] Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada
    Chen, DK
    McGeer, A
    de Azavedo, JC
    Low, DE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (04) : 233 - 239
  • [6] Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI
  • [7] Macrolide resistance in bacteremic pneumococcal disease: Implications for patient management
    Daneman, N.
    McGeer, A.
    Green, K.
    Low, D. E.
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 43 (04) : 432 - 438
  • [8] At the threshold: Defining clinically meaningful resistance thresholds for antibiotic choice in community-acquired pneumonia
    Daneman, Nick
    Low, Donald E.
    McGeer, Alison
    Green, Karen A.
    Fisman, David N.
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 46 (08) : 1131 - 1138
  • [9] Brief report: Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
    Davidson, R
    Cavalcanti, R
    Brunton, JL
    Bast, DJ
    de Azavedo, JCS
    Kibsey, P
    Fleming, C
    Low, DE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (10) : 747 - 750
  • [10] Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults
    Eliakim-Raz, Noa
    Robenshtok, Eyal
    Shefet, Daphna
    Gafter-Gvili, Anat
    Vidal, Liat
    Paul, Mical
    Leibovici, Leonard
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (09):
1234